Literature DB >> 16953911

Intrarenal pseudoaneurysm after percutaneous nephrolithotomy. Angiotomographic assessment and endovascular management.

M F Massulo-Aguiar1, Christiane M Campos, N Rodrigues-Netto.   

Abstract

We report a case of intrarenal pseudoaneurysm of the right kidney after percutaneous nephrolithotomy (PCNL) in supine position. Diagnosis was established by angiotomography with a 3-D reconstruction. Treatment was successfully achieved by endovascular occlusion using N-butyl-2-cyanoacrylate.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16953911     DOI： 10.1590/s1677-55382006000400009

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN： 1677-5538            Impact factor:   1.541


  5 in total

1.  Emerging role of multi-detector computed tomography in the diagnosis of hematuria following percutaneous nephrolithotomy: A case scenario.

Authors:  S E Sivanandam; Georgie Mathew; Sanjay H Bhat
Journal:  Indian J Urol       Date:  2009-07

2.  [Combined flexible and semirigid ureteroscopy with laser lithotripsy. Alternative to percutaneous nephrolithotomy of complex EWSL refractory nephrolithiasis].

Authors:  A K Ebert; W Schafhauser
Journal:  Urologe A       Date:  2008-08       Impact factor: 0.639

3.  Endovascular covered stenting for the management of post-percutaneous nephrolithotomy renal pseudoaneurysm: a case report.

Authors:  Prodromos Philippou; Konstantinos Moraitis; Tamer El-Husseiny; Hassan Wazait; Junaid Masood; Noor Buchholz
Journal:  J Med Case Rep       Date:  2010-09-23

4.  Glued angiocatheter: a rare complication of intrarenal pseudoaneurysm glue angioembolization.

Authors:  Varun Sharma; Santosh Kumar; Sk Singh; Ak Mandal
Journal:  Korean J Urol       Date:  2014-06-16

5.  Clinical efficacy and safety of transcatheter embolization for vascular complications after percutaneous nephrolithotomy.

Authors:  Necdet Poyraz; Mehmet Balasar; İbrahim Erdem Gökmen; Osman Koç; Mehmet Giray Sönmez; Arif Aydın; Yunus Emre Göger; Ahmet Öztürk
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-07-20       Impact factor: 1.195
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.